Balance Right in Multiple Sclerosis (BRiMS): A guided self-management programme to reduce falls and improve quality of life, balance and mobility in people with secondary progressive multiple sclerosis: a protocol for a feasibility randomised controlled trial by Gunn, H et al.
Author’s draft of an abstract of a presentation made at the 22nd Annual RIMS Conference 2017 and 
published in the journal ‘Multiple Sclerosis Journal’ May 2017 vol. 23 issue 6 page 878 
http://journals.sagepub.com/doi/pdf/10.1177/1352458517701017 
 
Balance Right in Multiple Sclerosis (BRiMS): A guided self-management 
programme to reduce falls and improve quality of life, balance and mobility in 
people with secondary progressive multiple sclerosis: a protocol for a 
feasibility randomised controlled trial 
 
Gunn H1,  
Andrade J2,  
Paul L3,  
Miller L3,4,  
Creanor S5,6,  
Green C7,  
Marsden J1,  
Ewings P8,  
Berrow M5,  
Vickery J5,  
Barton A9,  
Marshall B10,  
Zajicek J11, 
 Freeman JA1  
 
1 Faculty of Health and Human Sciences, School of Health Professions, Plymouth 
University, Peninsula Allied Health Centre, Derriford Rd, Plymouth, PL6 8BH  
2 Faculty of Health and Human Sciences, School of Psychology, Portland Square 
Building, Drake Circus Campus, Plymouth, PL4 8AA 
3 School of Health & Life Sciences, Glasgow Caledonian University, Cowcaddens 
Road, Glasgow, G4 0BA  
4 Douglas Grant Rehabilitation Unit, Ayrshire Central Hospital, Kilwinning Rd, Irvine, 
KA12 8SS  
5 Peninsula Clinical Trials Unit at Plymouth University (PenCTU), Peninsula Schools 
of Medicine and Dentistry, Room N16, Plymouth Science Park, Plymouth, PL6 8BX  
6 Department of Medical Statistics and Bioinformatics, Peninsula Schools of 
Medicine and Dentistry, Room N15, Plymouth Science Park, Plymouth, PL6 8BX  
7 University of Exeter Medical School, Health Economics Group, University of 
Exeter, St Luke’s Campus, Exeter, EX1 2LU  
8 NIHR Research Design Service (South West), Musgrove Park Hospital, Taunton, 
TA1 5DA  
9 NIHR Research Design Service, Peninsula Schools of Medicine and Dentistry, 
ITTC Building, Plymouth Science Park, Plymouth, PL6 8BX  
10 Service User Representative  
11 School of Medicine, Medical and Biological Sciences, University of St Andrews, 
North Haugh, St Andrews, KY16 9TF  
 
Background:  
Impaired mobility is a cardinal feature of multiple sclerosis (MS). By the secondary 
progressive phase, balance, mobility and physical activity levels are significantly 
compromised; an estimated 70% of people with secondary progressive MS fall 
regularly. Our ongoing research has systematically developed ‘Balance Right in MS’ 
(BRiMS), an innovative, manualised 13-week safe mobility and falls self- 
management programme tailored to the needs of people with MS. Our eventual aim 
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is to assess the clinical and cost effectiveness of BRiMS via a fully powered, 
multicentre, assessor-blinded randomised controlled trial (RCT). This feasibility study 
will assess the acceptability of the intervention and achievability of running such a 
trial.  
 
Methods/ Design: This is a pragmatic multi-centre feasibility RCT with blinded 
outcome assessment. Sixty ambulant people with secondary progressive MS who 
self-report two or more falls in the previous six months will be randomly allocated 1:1 
to either the BRiMS programme plus usual care or to usual care alone. All 
participants will be assessed at baseline and followed up at 15 weeks and 27 weeks 
post randomisation.  
 
Outcomes:  
• Feasibility outcomes, including recruitment, retention and completion 
• Assessment of the proposed outcome measures for the anticipated definitive 
trial (including measures of walking, quality of life, falls, balance and activity 
level)  
• Measures of adherence to the BRiMS programme  
• Data to inform the economic evaluation in a future trial  
• Process evaluation (assessment of treatment fidelity and qualitative 
evaluation of participant and treating therapist experience).  
 
Conclusion:  
The BRiMS intervention addresses an issue which is a key concern for MS service 
users and providers. This feasibility trial will provide important insights into the 
acceptability of the BRiMS intervention and the practicality of running a full-scale 
trial, and will enable a protocol to be finalised for use in the definitive trial. 
 
Trial Registration: ISRCTN13587999 
